<DOC>
	<DOCNO>NCT02757976</DOCNO>
	<brief_summary>This trial compare two strategy patient Heart Failure , Left Ventricular systolic dysfunction , intermediate QRS duration . The control group conventional CRT . The experimental group LVendo CRT</brief_summary>
	<brief_title>Resynchronization Ambulatory Heart Failure Trial - LV Endocardial Acute Hemodynamic Study</brief_title>
	<detailed_description>Patients randomize Conventional CRT receive CRT device without ICD . Device implantation perform within 10 work day randomization . Patients randomize LV endocardial CRT receive CRT device without ICD , place time frame RA RV lead implanted conventional CRT group . The device implant facility capacity perform trans-atrial septal puncture ultrasound guidance . The LV lead place use trans-atrial septal approach use specially design puncture tool LVendo delivery tool kit specifically design study</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<criteria>Patients NYHA Class II III ambulatory IV HF symptom Optimal HF Medical Therapy least 3 month ( 2009 ACCF/AHA , ESC 2012 ) LVEF le equal 35 % Sinus rhythm ( paroxysmal atrial fibrillation ) QRS morphology nonRBBB QRS duration equal 120 m , less 150 m Patients able receive chronic oral anticoagulation Patients pacemaker ICD meet criterion may upgrade CRTD CRTP Patients mitral tricuspid prosthetic valve Patients RBBB Patients LV thrombus Patients permanent atrial fibrillation Patients contraindication oral anticoagulation Inhospital patient acute cardiac noncardiac illness require intensive care Acute coronary syndrome ( include MI ) &lt; 4 week Coronary revascularization ( CABG PCI ) &lt; 3 month Uncorrected uncorrectable primary valvular disease Restrictive , hypertrophic reversible form cardiomyopathy Severe primary pulmonary disease cor pulmonale Expected undergo cardiac transplantation within one year ( status I ) Patients life expectancy le one year noncardiac cause . Patients include clinical trial affect objective study Those unable unwilling provide inform consent Those history noncompliance medical therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>